Exchange: NASDAQ·Updated 12:14 PM EDT
INO logo

INO Inovio Pharmaceuticals Inc

$1.40
$0.035
(2.57%)
Today
Reported EarningsAug 12
Mkt Cap$140.62M
Vol911,303.00

About INO

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
52

Neutral Sentiment

How do you feel about INO?

Advertisement|Remove ads.